Servicio Canario de la Salud

Organización

Health technology assessment reports on newborn screening

Actualizado a: [05/12/2023]

El interés internacional por los informes relacionados con cribado neonatal explica la creación de esta sección específica. Los informes completos están publicados en español y se encuentran disponibles en el apartado Ministerio de Sanidad.

Reports 2015

Cost-effectiveness of the newborn screening of 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMG) [18/02/2016].

Reports 2014

Cost-effectiveness of the newborn screening of long-chain acyl-CoA dehydrogenase deficiency [25/05/2015].
Cost-effectiveness of the newborn screening of primary carnitine deficiency [26/05/2015].

Reports 2013

Cost-effectiveness of the newborn screening of tyrosinaemia type 1 [26/05/2015].
Cost-effectiveness of the newborn screening of congenital adrenal hyperplasia [26/05/2015].
Cost-effectiveness of the newborn screening of classic galactosemia [26/05/2015].
Cost-effectiveness of the newborn screening of biotinidase deficiency [26/05/2015].

Reports 2012

Cost-effectiveness of the newborn screening of cystic fibrosis in Spain [26/05/2015].
Cost-effectiveness of the newborn screening of sickle cell disease [26/05/2015].
Cost-effectiveness of the expanded newborn screening of congenital errors of metabolism using tandem mass spectrometry [26/05/2015].

Reports 2006

Cost-effectiveness of the newborn screening of congenital errors of metabolism using tandem mass spectrometry [26/05/2015].